Literature DB >> 15100421

Can creatinine clearance be accurately predicted by formulae in octogenarian in-patients?

E Rimon1, N Kagansky, L Cojocaru, J Gindin, A Schattner, S Levy.   

Abstract

BACKGROUND: As serum creatinine is relatively inaccurate for estimating renal function, prediction formulae are commonly used for more precise renal function estimation. However, these equations have not been studied in acutely hospitalized octogenarian patients. AIM: To compare three commonly used formulae for estimating GFR to measured creatinine clearance (CCR) in patients aged >/=80 years admitted to an acute geriatric department.
DESIGN: Prospective, observational study.
METHODS: Consecutive patients aged >/=80 years with urinary catheters, admitted over a 12-month period to the acute geriatric ward of a 600-bed university hospital, were enrolled in the study. All had an accurate 24-h urinary collection, as well as serum and urinary urea and creatinine determinations. CCR was calculated and compared with GFRs derived from the three formulae.
RESULTS: Of the 154 patients enrolled in the study, 107 (69.5%) had normal serum creatinine (</=1.4 mg/dl), but 77/107 (50.0%) of these had measured CCR </=60 ml/min/1.73 m(2). Mean CCR was 45.1 ml/min/1.73 m(2) declining at the rate of 1.1 ml/min/1.73 m(2) each year. Only 9% of patients according to the Cockcroft and Jelliffe formulae, and 17% by the MDRD formula, fell within -10% and +10% of the measured CCR, which were the limits of agreement decided prior to the initiation of the study. DISCUSSION: Many elderly in-patients with moderate renal dysfunction will remain misidentified by relying on serum creatinine or commonly used prediction equations. The best practical approach in these patients is to avoid potentially nephrotoxic drugs and drugs excreted mainly through the kidneys.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15100421     DOI: 10.1093/qjmed/hch051

Source DB:  PubMed          Journal:  QJM        ISSN: 1460-2393


  8 in total

1.  Effect of creatinine clearance on patterns of toxicity in older patients receiving adjuvant chemotherapy for breast cancer.

Authors:  Arti Hurria; Anju Hurria; Kelly Brogan; Katherine S Panageas; Carol Pearce; Larry Norton; Ann Jakubowski; Jane Howard; Clifford Hudis
Journal:  Drugs Aging       Date:  2005       Impact factor: 3.923

2.  Age-dependent decline in renal function in patients with lung cancer.

Authors:  Gen Ohara; Koichi Kurishima; Kensuke Nakazawa; Mio Kawaguchi; Katsunori Kagohashi; Hiroichi Ishikawa; Nobuyuki Hizawa; Hiroaki Satoh
Journal:  Oncol Lett       Date:  2012-04-05       Impact factor: 2.967

Review 3.  Methods of Estimating Kidney Function for Drug Dosing in Special Populations.

Authors:  Laura A Hart; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2018-08       Impact factor: 6.447

4.  Renal functions in obstructive sleep apnea patients.

Authors:  Meral Uyar; Vedat Davutoğlu; Nevhiz Gündoğdu; Deniz Kosovalı; İbrahim Sarı
Journal:  Sleep Breath       Date:  2015-06-18       Impact factor: 2.816

5.  Prescribing optimization method for improving prescribing in elderly patients receiving polypharmacy: results of application to case histories by general practitioners.

Authors:  A Clara Drenth-van Maanen; Rob J van Marum; Wilma Knol; Carolien M J van der Linden; Paul A F Jansen
Journal:  Drugs Aging       Date:  2009       Impact factor: 3.923

6.  Kidney function and clinical recommendations of drug dose adjustment in geriatric patients.

Authors:  Marlies Karsch-Völk; Elisa Schmid; Stefan Wagenpfeil; Klaus Linde; Uwe Heemann; Antonius Schneider
Journal:  BMC Geriatr       Date:  2013-09-10       Impact factor: 3.921

7.  Renal function and ultrasound imaging in elderly subjects.

Authors:  Luca Zanoli; Giulia Romano; Marcello Romano; Stefania Rastelli; Francesco Rapisarda; Antonio Granata; Pasquale Fatuzzo; Mariano Malaguarnera; Pietro Castellino
Journal:  ScientificWorldJournal       Date:  2014-12-04

Review 8.  Clinical pharmacology of cancer therapies in older adults.

Authors:  A Hurria; S M Lichtman
Journal:  Br J Cancer       Date:  2008-02-05       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.